President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated.He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election.
Soon after, the tributes began to pour in. Many of them focused on Biden’s healthcare record. He “was propelled into office in no small part by his health care agenda,” Axios noted. As vice president, he launched the Cancer Moonshot, a plan to revolutionize treatment and end the disease as we know it. He continued that effort throughout his presidency, all while delivering on campaign promises to expand Obamacare and use government power to cap prescription drug prices.
That’s a litany of foibles — not anything to celebrate. His efforts to shore up Obamacare have cost taxpayers billions without doing anything to lower insurance costs. His price controls are already stifling pharmaceutical innovation — and will therefore undermine the goal of his Cancer Moonshot to end cancer as we know it.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Joe Biden Leaves Behind A Disastrous Healthcare Legacy
Sally C. Pipes
President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated. He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election.
Soon after, the tributes began to pour in. Many of them focused on Biden’s healthcare record. He “was propelled into office in no small part by his health care agenda,” Axios noted. As vice president, he launched the Cancer Moonshot, a plan to revolutionize treatment and end the disease as we know it. He continued that effort throughout his presidency, all while delivering on campaign promises to expand Obamacare and use government power to cap prescription drug prices.
That’s a litany of foibles — not anything to celebrate. His efforts to shore up Obamacare have cost taxpayers billions without doing anything to lower insurance costs. His price controls are already stifling pharmaceutical innovation — and will therefore undermine the goal of his Cancer Moonshot to end cancer as we know it.
Click to read the full article in Forbes.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.